Man with back pain Despite the increased spending on MSK therapies between 2010 and 2019, many MSK treatments simply aren’t providing a long-term solution, instead relying on “quick fix” injections or costly surgeries. (Photo: Shutterstock)

A new report finds that treatment of musculoskeletal (MSK) issues has doubled in recent years—with no improvement in patient outcomes.

The “State of MSK Report, 2021” was released by Hinge Health, a digital health company that specializes in MSK treatment. The report noted that MSK issues are a top health care cost for many employers, and that the new trend toward remote work may result in an increase in claims in this area, since many home workspaces are not set up to be ergonomically sound.


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.